Women Maintain NIH Funding Similar to Men: Study

Female PIs apply for fewer grants, but retain support once they get it.

Written byKerry Grens
| 1 min read
Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

While searching for reasons why women faculty members are underrepresented in the life sciences, researchers have looked at factors affecting the retention of female faculty, such as the ability to sustain funding. A new analysis finds that keeping the money rolling in doesn’t appear to be a factor. Of nearly 35,000 researchers who received funding from the National Institutes of Health (NIH) between 1991 and 2010, men and women maintain funding at roughly the same rates.

The authors, who published their report today (July 16) in PNAS, say the results contradict a “leaky pipeline” assumption that women lose funding more frequently than men. “We found that rather than leaving the NIH funding pool at much greater rates than men, women were much more dramatically underrepresented to begin with among first-time [research project grant] holders,” they write in their study, “composing only 30.66% of investigators in the analysis.”

The other differences ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • kerry grens

    Kerry served as The Scientist’s news director until 2021. Before joining The Scientist in 2013, she was a stringer for Reuters Health, the senior health and science reporter at WHYY in Philadelphia, and the health and science reporter at New Hampshire Public Radio. Kerry got her start in journalism as a AAAS Mass Media fellow at KUNC in Colorado. She has a master’s in biological sciences from Stanford University and a biology degree from Loyola University Chicago.

    View Full Profile
Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies